Breaking News
Phanes Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of Spevatamig in Combination with Chemotherapy for the Frontline Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Biotech Clinical Trials

Phanes Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of Spevatamig in Combination with Chemotherapy for the Frontline Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Source: news.google.com

Published: Jun 23, 2026 04:27

Read Original Source
Phanes Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of Spevatamig in Combination with Chemotherapy for the Frontline Treatment of Metastatic Pancreatic Ductal Adenocarcinoma  BioSpace
Detailed source content is still being fetched from the original article. Use the source link above for the live story.

Related Stories

More from this topic and section

50 Randomized Clinical Trial of Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy (COPE Study)
CancerNetwork · 1 hour ago Biotech

50 Randomized Clinical Trial of Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy (COPE Study)

50 Randomized Clinical Trial of Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy (COPE Study)  CancerNetwork

#Clinical Trials

Add Shortcut

Add Newsfeed to your home screen

Open this site faster like an app from your phone home screen.

X in 3s